Insulin Glulisine

Common brands: Apidra, Lantus, Apidra Solostar, Lantus Solostar, Toujeo

Top reporter: Sanofi-Aventis U.S. Llc

Insulin Analog [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Loop Diuretic [EPC]HMG-CoA Reductase Inhibitor [EPC]Platelet Aggregation Inhibitor [EPC]
10,018
Total Reports
2,330
Serious Reports
803
Death Reports
30
Reported Reactions
Death Report Ratio: High (8.02%)

Patient Demographics

Male
4,391
Female
4,942

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Insulin Glulisine.

# Reaction Reports % of Total
1 BLOOD GLUCOSE INCREASED 1,534
14.1%
2 HYPOGLYCAEMIA 764
7.0%
3 HYPERGLYCAEMIA 639
5.9%
4 DRUG INEFFECTIVE 571
5.2%
5 BLOOD GLUCOSE DECREASED 446
4.1%
6 DIZZINESS 402
3.7%
7 MALAISE 394
3.6%
8 DYSPNOEA 383
3.5%
9 NAUSEA 371
3.4%
10 VOMITING 337
3.1%
11 ACUTE KIDNEY INJURY 305
2.8%
12 FATIGUE 302
2.8%
13 ASTHENIA 294
2.7%
14 DIARRHOEA 283
2.6%
15 PAIN 272
2.5%
16 BLOOD GLUCOSE ABNORMAL 270
2.5%
17 FALL 270
2.5%
18 DIABETES MELLITUS INADEQUATE CONTROL 269
2.5%
19 HEADACHE 260
2.4%
20 OFF LABEL USE 259
2.4%
21 GLYCOSYLATED HAEMOGLOBIN INCREASED 256
2.3%
22 RENAL FAILURE 244
2.2%
23 DIABETIC KETOACIDOSIS 242
2.2%
24 VISUAL IMPAIRMENT 241
2.2%
25 HYPERHIDROSIS 234
2.1%
26 PRODUCT QUALITY ISSUE 224
2.1%
27 PNEUMONIA 211
1.9%
28 WEIGHT DECREASED 210
1.9%
29 DEATH 209
1.9%
30 LOSS OF CONSCIOUSNESS 205
1.9%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.